Thomas G. Wollman
Consumers Pay When Generic Drug Companies Collude. Here’s a Way to Stop Them.
Price-fixing by pharmaceutical cartels can cost billions, and the threat of lawsuits isn’t enough to deter it.
Researchers: Amanda Starc and Thomas G. Wollman
June 1, 2022